Original post on mastodon.social

Another fiber related article:

“ The sources highlight the crucial role of dietary fiber in preventing and reversing non-alcoholic fatty liver disease (NAFLD), a condition affecting millions worldwide. Dr. Greger's recommendations emphasize that fiber, abundant in whole plant foods, is […]

MCT4 alleviates #NAFLD by promoting #LipidCatabolism and reducing #steatosis through regulation of metabolic and inflammatory pathways, highlighting its role as a key lactate transporter and promising therapeutic target in #FattyLiverDisease.

#OpenAccess: doi.org/10.1016/j.ge...

Prevalence and dietary factors associated with nonalcoholic fatty liver disease in a sample of obese middle-aged Egyptian women - Scientific Reports This study investigated the prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) among a sample of middle-aged obese Egyptian women and explored the associations between nutritional status, dietary ...

New in @nature.com: ""Furthermore, a significant positive correlation was detected between #NAFLD score and total dietary fat, #saturatedfat and #cholesterol which was more prominent as the degree of fatty liver worsens." #liverdisease #hepatology
www.nature.com/articles/s41...

Role of Intermittent Fasting (IF) in the management of Metabolic Dysfunction–Associated Steatotic… Mechanistic insights into insulin sensitivity, circadian alignment, autophagy, and gut–liver axis regulation.

Intermittent fasting helps rebalance metabolism by improving insulin sensitivity, gut health, and autophagy, reducing liver fat. Time‑restricted eating offers a practical, non‑drug strategy to protect liver health and curb MASLD’s rise.

medium.com/@AutophagyFa...

#MASLD #NAFLD #IntermittentFasting

Protective Effects of Berberine on Nonalcoholic Fatty Liver Disease in db/db Mice via AMPK/SIRT1 Pathway Activation

This study explores the hepatoprotective effects of #Berberine in #NAFLD, improving #InsulinResistance, lipid profiles, & #LiverInjury, while suppressing #OxidativeStress, #Inflammation, & #Apoptosis via activation of #AMPK/#SIRT1. #medsky

To read: doi.org/10.1007/s115...

Monocyte to High-density Lipoprotein Cholesterol Ratio as a Predictor of Nonalcoholic Fatty Liver Disease in Childhood Obesity

Higher monocyte to high-density lipoprotein cholesterol ratio (MHR) is an independent predictor of #NAFLD in children with #obesity, linking #inflammation to disease risk and highlighting MHR as a useful #marker for early detection and intervention.
Read: doi.org/10.1007/s115...

Our article on the Mediterranean diet and NAFLD continues to gain impact: 4,404 views 📈
A 6-month lifestyle intervention improves oxidative stress, inflammation, intrahepatic fat, and cardiorespiratory fitness🌱💚
🔗 www.mdpi.com/2076-3921/11...
#MedDiet #NAFLD #MDPI #Antioxidants

Using mouse gain- and loss-of-function models, this study demonstrates that increased hepatic IRF8 activates the BMAL1/PPARγ axis to promote lipid accumulation, driving #HepaticSteatosis and its progression to #NAFLD.

#OpenAccess: doi.org/10.1016/j.ge...

Night-time changes in metabolism may be driving common liver disease, study finds | NIHR Oxford Biomedical Research Centre

Are night-time metabolic changes driving the most common liver disease? Our research found that #MASLD follows a strong day-night pattern, and the changes that drive it happen overnight, when the body is least able to process sugar and fat. #NAFLD oxfordbrc.nihr.ac.uk/night-time-c...
1/4

MCT4 regulates lipid metabolism & inflammation, reducing lipid accumulation in NAFLD.
#NAFLD #Metabolism #Inflammation #LiverHealth #MCT4
www.sciencedirect.com/science/arti...

IRF8 worsens NAFLD through the BMAL1/PPARγ axis, linking circadian regulation, metabolism, and hepatic inflammation—revealing promising therapeutic angles.
#NAFLD #LiverDisease #InflammationMechanisms #Lipogenesis #Transcriptional regulation
www.sciencedirect.com/science/arti...

#MCT4 regulates lipid metabolism and inflammation in #NAFLD, with its overexpression reducing #steatosis while its loss drives #LipidAccumulation, positioning MCT4 as a central regulator of #MetabolicPathways and a promising therapeutic target.

#OpenAccess: doi.org/10.1016/j.ge...

Therapeutic Potential of Fisetin in Hepatic Steatosis: Insights Into Autophagy Pathway Regulation and Endoplasmic Reticulum Stress Alleviation in High-Fat Diet-Fed Mice Can fisetin treat fatty liver? Study finds FSN reduces lipid accumulation via AMPK/mTOR pathway. #NAFLD #Autophagy

Can fisetin treat fatty liver? Study finds FSN reduces lipid accumulation via AMPK/mTOR pathway. #NAFLD #Autophagy
www.rimpacts.com/rd/p?c=10096... 📄DOI: doi.org/10.1371/jour...

The Efficacy of Plantago Major Seed on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial Plantago major may significantly improve liver health in NAFLD patients. Could this natural supplement become a key player in fatty liver management? #NAFLD #LiverHealth

Plantago major may significantly improve liver health in NAFLD patients. Could this natural supplement become a key player in fatty liver management? #NAFLD #LiverHealth#TPM #TUMS www.rimpacts.com/rd/p?c=10048... 📄DOI: doi.org/10.1155/2021...

Microscopy-Guided Spatial Proteomics Reveals Novel Proteins at the Mitochondria-Lipid Droplet Interface and Their Role in Lipid Metabolism Mitochondria-lipid droplet (LD) interactions play a critical role in lipid metabolism and the progression of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD). However, the dynamic ...

Using Microscoop®, we investigated protein interactions in nanoscale contact zones between lipid droplets and mitochondria, revealing key drivers of disease progression in NAFLD/MASH.

Full study → www.biorxiv.org/content/10.1...

#Microscoop #SpatialProteomics #NAFLD #MASH #BioRxiv

"Given that ALD and metabolic dysfunction-associated steatotic liver disease share fructose-dependent mechanisms, targeting fructose metabolism may offer a novel therapeutic approach for treating alcohol use disorder and related liver injury."

#diet #health #lcl6 #nafld #mash

Higher Systemic Immune-Inflammation Index is associated with non-alcoholic fatty liver disease; Hedge’s g = 0.11 and odds ratio (OR) = 1.45. Further longitudinal studies are needed. #NAFLD #SII #SystemicInflammation #Biomarker #MetaAnalysis journals.lww.com/annals-of-me...

This review explores how #RibosomeBiogenesis, involving rRNA, ribosomal proteins, and biogenesis factors, impacts #LiverRegeneration, #HepatitisC, #NAFLD, and #LiverCancer, emphasizing its potential as a novel therapeutic strategy. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Non-Alcoholic Liver Disease: Risks & Metabolism | MindBodyGreen Discover the surprising link between your metabolism and liver health. Learn about the silent liver disease affecting 32% & how to manage it.

LifeNextDaily News!
32% of people are affected by this liver disease...and it's NOT linked to alcohol. Learn how it's connected to your metabolism. #NAFLD #LiverHealth #MetabolicHealth

Click here↓↓↓

Non Alcoholic Fatty Liver Disease Market Report, 2035 Non-Alcoholic Fatty Liver Disease NAFLD Market 2025, Industry to reach 3.8 USD billion, at a 5.98% CAGR by growing size, share, top company analysis, segments research, trends and forecast to 2035

Growing awareness & treatments are driving the #NAFLD market 📈🩺 Full report 👉 www.marketresearchfuture.com/reports/non-... #LiverHealth #PharmaTrends

In a new study, people who consumed higher amounts of both artificially sweetened and sugary drinks were at increased risk of a serious condition where fat builds up in the liver.

youtu.be/4oxYrDTJkjk

#liverhealth #MASLD #NAFLD #dietdrinks #sugarydrinks #healthrisk #liverdisease #metabolicsyndrome

Meta-analysis reveals rising prevalence of nonalcoholic fatty liver disease (NAFLD): 13% globally, 47% in obese children. Higher in males. Urgent need for more research as childhood obesity increases.

#Meded #SoMe4PedSurg #Pediatrics #NAFLD

link.springer.com/article/10.1...

Could a supplement made from whole tomatoes help fight fatty liver disease? 🍎📃
A new preprint investigates a whole tomato-based food supplement for its potential to manage #NAFLD at a cellular level. 🧪
Read the study: buff.ly/evGp1Fs

#AcademicSky #Edusky #AcWri #publicHealth

🫀📊 New research reveals link between MASLD and undiagnosed heart failure. Time to rethink screening strategies. #MASLD #LiverHealth #NAFLD #HF @dcrinews.bsky.social @kwegermann.bsky.social @dukemedschool.bsky.social
Read it here --> t.co/OjMFmqxc31

Association Between Healthful Plant‐Based Dietary Pattern and Adiposity Measures Trajectories and Future Metabolic Diseases Risk: A Prospective Cohort Study A healthy plant-based dietary pattern assists in maintaining normal body size over time. Concurrently, long-term stabilization of a normal body size may be linked to a reduced risk of metabolic disea...

New: "Our results suggest that increasing healthy #plantbased dietary intake may reduce the long‐term risk of #obesity and that maintaining obesity measures at a normal level over time may reduce the risk of metabolic disease." #diabetes #type2diabetes #NAFLD
onlinelibrary.wiley.com/doi/10.1002/...

Shilpa Medicare's NorUDCA Gains Notable Approval as First Global NAFLD Therapy Shilpa Medicare's NorUDCA is the world's first approved therapy for Non-Alcoholic Fatty Liver Disease, offering hope to millions affected globally.

Shilpa Medicare's NorUDCA Gains Notable Approval as First Global NAFLD Therapy #India #Shilpa_Medicare #Raichur #NorUDCA #NAFLD

Shilpa Medicare's NorUDCA Achieves Milestone as First Approved NAFLD Therapy Shilpa Medicare has made history with NorUDCA, the world's first approved therapy for NAFLD, offering hope for over 1 billion patients globally.

Shilpa Medicare's NorUDCA Achieves Milestone as First Approved NAFLD Therapy #India #Shilpa_Medicare #Raichur #NorUDCA #NAFLD

Shilpa Medicare's NorUDCA Marks a Revolutionary Approval for NAFLD Treatment Shilpa Medicare's groundbreaking therapy NorUDCA is the first globally approved treatment for NAFLD, promising hope for over a billion affected individuals.

Shilpa Medicare's NorUDCA Marks a Revolutionary Approval for NAFLD Treatment #India #Shilpa_Medicare #Raichur #NorUDCA #NAFLD

Shilpa Medicare Makes Groundbreaking Move with NorUDCA, First NAFLD Therapy Approved Worldwide Shilpa Medicare's NorUDCA is the first-ever therapy approved globally for Non-Alcoholic Fatty Liver Disease, offering hope to millions suffering worldwide.

Shilpa Medicare Makes Groundbreaking Move with NorUDCA, First NAFLD Therapy Approved Worldwide #India #Shilpa_Medicare #Raichur #NorUDCA #NAFLD

Mechanistic insights on how MCT4, a lactate transporter, inhibits #HepaticSteatosis & subsequently mitigates #NAFLD progression by regulating a group of hub genes involved in #LipidMetabolism & inflammation. #FattyLiver #medsky
#OpenAccess: